Patents-Review.com
ClassID:

96482 ⎘

C07J5/0015 - CPC Classification

Classification description:

Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16

Recent Application in this class:
#1
20260116913
2026-04-30

NEUROSTEROID COMPOUNDS AND METHODS FOR THEIR PREPARATION AND USE IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS

 #2
20260034146
2026-02-05

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #3
20250319106
2025-10-16

19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF

 #4
20250206774
2025-06-26

C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS

 #5
20240409576
2024-12-12

-ent-19-norprogesterone, compositions and uses thereof to treat traumatic brain injury (TBI), including concussions-

 #6
20230391816
2023-12-07

NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF

 #7
20230287037
2023-09-14

3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF

 #8
20230250131
2023-08-10

HYDROXYSTEROID COMPOUNDS

 #9
20230190770
2023-06-22

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #10
20230151052
2023-05-18

NEUROSTEROID COMPOUNDS AND METHODS FOR THEIR PREPARATION AND USE IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS

 #11
20220153776
2022-05-19

ANTAGONISTS OF CB1 RECEPTOR

 #12
20220110950
2022-04-14

19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof

 #13
20220009957
2022-01-13

Methods for Preparing Bile Acids

 #14
20210403502
2021-12-30

Neuroactive steroids, compositions, and uses thereof

 #15
20210308149
2021-10-07

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #16
20210277049
2021-09-09

Cocrystal of progesterone and preparation method and use thereof

 #17
20210238220
2021-08-05

Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders

 #18
20210094981
2021-04-01

Neuroactive steroids, compositions, and uses thereof

 #19
20210040141
2021-02-11

3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF

 #20
20200369712
2020-11-26

Methods for preparing bile acids

 #21
20200223884
2020-07-16

3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF

 #22
20200155576
2020-05-21

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

 #23
20200113916
2020-04-16

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #24
20200016178
2020-01-16

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

 #25
20190169226
2019-06-06

Neuroactive steroids, compositions, and uses thereof

 #26
20190137507
2019-05-09

Quantitative profiling of progesterone metabolites for the prediction of spontaneous preterm delivery

 #27
20190071465
2019-03-07

ANTAGONISTS OF CB1 RECEPTOR

 #28
20180327444
2018-11-15

Chemical compounds and use thereof for improving muscular quality

 #29
20180311262
2018-11-01

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

 #30
20180141971
2018-05-24

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

 #31
20180125864
2018-05-10

Method for screening regulator of mitochondrial fission

 #32
20170342103
2017-11-30

3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof

 #33
20170247406
2017-08-31

Neuroactive steroids, compositions, and uses thereof

 #34
20170246191
2017-08-31

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

 #35
20170190732
2017-07-06

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

 #36
20170152282
2017-06-01

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

 #37
20160272670
2016-09-22

STEROIDS HAVING INCREASED WATER SOLUBILITY AND RESISTANCE AGAINST METABOLISM AND METHODS FOR THEIR PRODUCTION

 #38
20160168190
2016-06-16

C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS

 #39
20160145294
2016-05-26

Antagonists of CB1 receptor

 #40
20160108080
2016-04-21

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

 #41
20150337006
2015-11-26

Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof

 #42
20150315230
2015-11-05

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #43
20150291654
2015-10-15

3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF

 #44
20140235600
2014-08-21

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

 #45
20140200200
2014-07-17

Antagonists of CB1 receptor

 #46
20140011779
2014-01-09

Steroids having increased water solubility and resistance against metabolism, and methods for their production

 #47
20130281421
2013-10-24

Steroids having increased water solubility and resistance against metabolism and methods for their production

 #48
20100204497
2010-08-12

Process For The Preparation of 7 alpha-Methylsteroids

 #49
20080119416
2008-05-22

Steroids having increased water solubility and resistance against metabolism, and methods for their production

 #50
20060140816
2006-06-29

Sterilization of beclomethasone drug particles for pulmonary delivery

 #51
20050176976
2005-08-11

GABAmodulating neurosteroids

 #52
20050090476
2005-04-28

Process for the preparation of 7alpha-methylsteroids